Technical note: Effects of rumen passage on fluoxetine bioavailability in serum and effects of fluoxetine on serum prolactin concentration and demeanor in ewes

Journal of Animal Science

Volumn 88, Issue 11, 2010, Pages 3611-3616

  Yates, D T ^a   Strosser, G L ^a   Black, P L ^a   Halalsheh, R A ^a   Lankford, L M ^a   Hernandez, L L ^b   Loest C A ^a   Ross, T T ^a  

^a NEW MEXICO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Ewe; Fluoxetine; Selective serotonin reuptake inhibitor

Indexed keywords

FLUOXETINE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BIOAVAILABILITY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; GASTROINTESTINAL MOTILITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RUMINANT STOMACH; SHEEP;

ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL AVAILABILITY; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; GASTROINTESTINAL MOTILITY; PROLACTIN; RUMEN; SEROTONIN UPTAKE INHIBITORS; SHEEP;

OVIS ARIES;

EID: 78049320452     PISSN: 00218812     EISSN: 15253163     Source Type: Journal    
DOI: 10.2527/jas.2010-3076     Document Type: Article

References (20)

1. Anderson, P. O., S. L. Pochop, and A. S. Manoguerra. 2003. Adverse drug reactions in breastfed infants: Less than imagined. Clin. Pediatr. (Phila.) 42:325-340.
2. Bagnyuk, V. M., I. Y. Kulikova, and O. A. Berestecky. 1985. The role of bacteria, capable to lysis of microbial biomass, in the rumen of ruminants. Izv. Akad. Nauk SSSR. Ser. Biol. 4:552-561.
3. Breggin, P. R. 2004. Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis. Int. J. Risk Saf. Med. 16:31-49.
4. Burke, W. J., S. E. Hendricks, D. McArthur-Miller, D. Jacques, D. Bessette, T. McKillup, T. Stull, and J. Wilson. 2000. Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: Results of a placebo-controlled, randomized clinical trial. J. Clin. Psychopharmacol. 20:423-427.
5. Chambers, C. D., P. O. Anderson, R. G. Thomas, L. M. Dick, R. J. Felix, K. A. Johnson, and K. L. Jones. 1999. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 104:e61. (Abstr.)
6. Chaubey, A., R. Parshad, S. Koul, S. C. Taneja, and G. N. Qazi. 2006. Arthrobacter sp. Lipase immobilization for improvement in stability and enantioselectivity. Appl. Microbiol. Biotechnol. 73:598-606.
7. Gartlehner, G., B. N. Gaynes, R. A. Hansen, P. Thieda, A. De-Veaugh-Geiss, E. E. Krebs, C. G. Moore, L. Morgan, and K. N. Lohr. 2008. Comparative benefits and harms of second-generation antidepressants: Background paper for the American College of Physicians. Ann. Intern. Med. 149:734-750.
8. Heller, T. A., T. Tobin, W. Karpiesiuk, H. H. Tai, J. D. Harkins, S. E. Magsig, and D. E. Schroedter. 1998. ELISA assay for fluoxetine. Page 263 in Proc. 12th Int. Conf. of Racing Analysts and Veterinarians, Vancouver, British Columbia, Canada. B. Laviolette and M. R. Koupai-Abyazani, ed.
9. Hernandez, L. L., C. M. Stiening, J. B. Wheelock, L. H. Baumgard, A. M. Parkhurst, and R. J. Collier. 2008. Evaluation of serotonin as a feedback inhibitor of lactation in the bovine. J. Dairy Sci. 91:1834-1844.
10. Kim, J., K. W. Riggs, and D. W. Rurak. 2004. Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep. Drug Metab. Dispos. 32:212-221.
11. Morrison, J. L., C. Chien, N. Gruber, D. Rurak, and W. Riggs. 2001. Fetal behavioural state changes following maternal fluoxetine infusion in sheep. Brain Res. Dev. Brain Res. 131:47-56.
12. Morrison, J. L., D. W. Rurak, C. Chien, D. J. Kennaway, N. Gruber, I. C. McMillen, and K. W. Riggs. 2005. Maternal fluoxetine infusion does not alter fetal endocrine and biophysical circadian rhythms in pregnant sheep. J. Soc. Gynecol. Investig. 12:356-364.
13. Pecins-Thompson, M., and C. L. Bethea. 1997. RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. Neuroendocrinology 65:335-343.
14. Redshaw, C. H., V. G. Wootton, and S. J. Rowland. 2008. Uptake of the pharmaceutical fluoxetine hydrochloride from growth medium by Brassicaceae. Phytochemistry 69:2510-2516.
15. Simon, G. E., J. Savarino, B. Operskalski, and P. S. Wang. 2006. Suicide risk during antidepressant treatment. Am. J. Psychiatry 163:41-47.
16. Spoon, R. A., and D. M. Hallford. 1989. Growth response, endocrine profiles and reproductive performance of fine-wool ewe lambs treated with ovine prolactin before breeding. Theriogenology 32:45-53.
17. Stahl, M. M. S., M. Lindquist, M. Pettersson, I. R. Edwards, J. H. Sanderson, N. F. A. Taylor, A. P. Fletcher, and J. S. Schou. 1997. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur. J. Clin. Pharmacol. 53:163-169.
18. Urban, R. J., and J. D. Veldhuis. 1991. A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women. Am. J. Obstet. Gynecol. 164:147-152.
19. van Nolte, J. E., C. A. Loest, A. V. Ferreira, J. W. Waggoner, and C. P. Mathis. 2008. Limiting amino acids for growing lambs fed a diet low in ruminally undegradable protein. J. Anim. Sci. 86:2627-2641.
20. Wong, D. T., F. P. Bymaster, and E. A. Engleman. 1995. Prozac (fluoxetine, Lilly 110140), the first selective serotonin reuptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci. 57:411-441.